<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22401" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Granuloma Faciale</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Al Dhafiri</surname>
            <given-names>Mahdi</given-names>
          </name>
          <aff>King Faisal University, Alhasa</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kaliyadan</surname>
            <given-names>Feroze</given-names>
          </name>
          <aff>Sree Narayana Institute of Medical Sciences</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mahdi Al Dhafiri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Feroze Kaliyadan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22401.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Granuloma faciale (GF) is a rare, benign, inflammatory skin disease, usually presenting as isolated, well-defined reddish-brown to violaceous asymptomatic papules, nodules or plaques showing follicular accentuation and telangiectasia. Granuloma faciale is most commonly seen in middle-aged white males between their second and seventh decades of life, although it has also been reported in childhood. It usually appears as a single lesion on the face, but can also present with multiple lesions on the face or elsewhere. Extrafacial GF locations may include the scalp, trunk, nasal cavity or extremities. The facial lesions most commonly present on the forehead, nose, or cheeks. This activity reviews the evaluation of a patient with granuloma faciale and the role of the interprofessional team in the management of this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the presentation of granuloma faciale.</p></list-item><list-item><p>Explain when granuloma faciale should be considered on differential diagnosis.</p></list-item><list-item><p>Outline the treatment of granuloma faciale.</p></list-item><list-item><p>Explore modalities to improve care coordination among interprofessional team members in order to optimize outcomes for patients affected by granuloma faciale.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22401&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22401">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22401.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Granuloma faciale (GF) is a rare, benign, inflammatory skin disease, usually presenting as isolated, well-defined reddish-brown to violaceous asymptomatic papules, nodules or plaques&#x000a0;showing follicular accentuation and telangiectasia. It was first described&#x000a0;as&#x000a0;'eosinophilic granuloma' in 1945 by Wigley JE.<xref ref-type="bibr" rid="article-22401.r1">[1]</xref> Granuloma faciale is most commonly seen in middle-aged white males (between the second and seventh decades of life), but it has been reported in childhood too.<xref ref-type="bibr" rid="article-22401.r2">[2]</xref><xref ref-type="bibr" rid="article-22401.r3">[3]</xref><xref ref-type="bibr" rid="article-22401.r4">[4]</xref>&#x000a0;It usually appears as a single lesion on the face, but occurrence can be as multiple lesions and/or extrafacial. Extrafacial&#x000a0;GF localizations are possible, including localization on the scalp, trunk, nasal cavity or extremities. The facial lesions most commonly present on the forehead, nose, or cheeks.<xref ref-type="bibr" rid="article-22401.r3">[3]</xref><xref ref-type="bibr" rid="article-22401.r5">[5]</xref></p>
      </sec>
      <sec id="article-22401.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of granuloma faciale is unknown, but&#x000a0;because of the localization&#x000a0;on mainly sun-exposed areas of the body, the thinking is that the condition is related to actinic damage. Other possible etiologies include allergy&#x000a0;and trauma.<xref ref-type="bibr" rid="article-22401.r6">[6]</xref>&#x000a0;Radiation therapy is considered to be another potential trigger.<xref ref-type="bibr" rid="article-22401.r7">[7]</xref></p>
      </sec>
      <sec id="article-22401.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Granuloma faciale is a relatively rare condition that occurs mainly in adult people from both sexes with a slight predilection in men. All races can be affected, but GF most commonly presents in whites.&#x000a0;The mean age of onset is around 52 years.<xref ref-type="bibr" rid="article-22401.r8">[8]</xref><xref ref-type="bibr" rid="article-22401.r9">[9]</xref></p>
      </sec>
      <sec id="article-22401.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathogenesis of GF is not well established. It is considered to be a variant of chronic cutaneous vasculitis possibly secondary&#x000a0;to an underlying localized Arthus phenomenon.<xref ref-type="bibr" rid="article-22401.r10">[10]</xref></p>
      </sec>
      <sec id="article-22401.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Specific histopathologic features have do not yet exist for granuloma faciale. The most frequent histologic features reported are the presence of Grenz zone, infiltration of neutrophils and telangiectasia.<xref ref-type="bibr" rid="article-22401.r3">[3]</xref></p>
        <p>The inflammatory infiltrates in the dermis are usually separated from the overlying epidermis by a narrow Grenz zone of the uninvolved dermis.&#x000a0;Dilated follicular ostia and/or follicular plugs are frequently observed.<xref ref-type="bibr" rid="article-22401.r3">[3]</xref><xref ref-type="bibr" rid="article-22401.r8">[8]</xref><xref ref-type="bibr" rid="article-22401.r2">[2]</xref></p>
        <p>The inflammatory infiltrates in the dermis are mostly perivascular and consist mainly of neutrophils, lymphocytes, and plasma cells. Eosinophils are also frequently observed.<xref ref-type="bibr" rid="article-22401.r3">[3]</xref><xref ref-type="bibr" rid="article-22401.r8">[8]</xref><xref ref-type="bibr" rid="article-22401.r2">[2]</xref>&#x000a0;&#x000a0;</p>
        <p>Vascular changes are frequent presentations, and they consist mainly of perivascular infiltrates which could penetrate the vascular wall and causing leukocytoclasis. However necrotizing vasculitis is very rare. Moreover, the presence of hemosiderin and red blood cell deposits are consistent with vascular injury.<xref ref-type="bibr" rid="article-22401.r3">[3]</xref><xref ref-type="bibr" rid="article-22401.r2">[2]</xref>&#x000a0;</p>
        <p>Direct immunofluorescence is not positive in all cases and not pathognomonic for granuloma faciale. Positive findings seen on direct immunofluorescence include granular deposits of IgG with less intense deposits of IgM, and in some cases, IgA, C3, and C1q localized in the perivascular areas or the basement membrane zone.<xref ref-type="bibr" rid="article-22401.r10">[10]</xref><xref ref-type="bibr" rid="article-22401.r3">[3]</xref></p>
      </sec>
      <sec id="article-22401.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Granuloma faciale typically presents as a chronic, progressive, asymptomatic, isolated, well-defined reddish-brown to a violaceous asymptomatic papule, nodule or plaques&#x000a0;showing follicular accentuation and telangiectasia. The most common sites are the face and other sun-exposed areas. Dermoscopy is a useful tool for the clinical evaluation of GF. Dermoscopy typically reflects the clinical and histological features. The most common dermoscopic features include: linear, arborizing vessels, dilated follicular openings and brown dots/ globules. The brown dots/ globules are considered to reflect hemosiderin deposition.<xref ref-type="bibr" rid="article-22401.r11">[11]</xref></p>
      </sec>
      <sec id="article-22401.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Granuloma faciale has a progressive, chronic course with recurrent acute phases, rather than having a distinct acute and chronic phase. It is therefore difficult to comment on the chronicity based on histopathology as cases might show overlapping features of acute and chronic inflammation.<xref ref-type="bibr" rid="article-22401.r3">[3]</xref> Laboratory evaluation is normal except for mild blood eosinophilia.<xref ref-type="bibr" rid="article-22401.r8">[8]</xref> Granuloma faciale is a benign condition, but spontaneous healing is rare, so most cases require therapeutic intervention, but presently available treatment options associated with significant chances of recurrence.<xref ref-type="bibr" rid="article-22401.r12">[12]</xref><xref ref-type="bibr" rid="article-22401.r13">[13]</xref></p>
      </sec>
      <sec id="article-22401.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment of granuloma faciale include is difficult, with variable clinical outcomes. Treatment modalities reported to be useful in granuloma faciale include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Topical treatment, which is considered as first-line therapy, and it includes topical corticosteroids or tacrolimus - topical dapsone is another option in GF</p>
          </list-item>
          <list-item>
            <p>Intralesional corticosteroids have been reported to be&#x000a0; effective in some cases</p>
          </list-item>
          <list-item>
            <p>Systemic treatment, including systemic corticosteroids and dapsone</p>
          </list-item>
          <list-item>
            <p>Phototherapy including psoralens plus ultraviolet A (PUVA)</p>
          </list-item>
          <list-item>
            <p>Other therapeutic modalities including lasers, cryotherapy, and surgical excision</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22401.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Several cutaneous conditions present with an appearance similar to granuloma faciale include. Clinical differential diagnosis includes sarcoidosis, discoid lupus erythematosus, rosacea, mycobacterial infections cutaneous deep fungal infections, cutaneous lymphoma, and basal cell carcinoma.<xref ref-type="bibr" rid="article-22401.r2">[2]</xref><xref ref-type="bibr" rid="article-22401.r5">[5]</xref><xref ref-type="bibr" rid="article-22401.r3">[3]</xref><xref ref-type="bibr" rid="article-22401.r14">[14]</xref></p>
        <p>Erythema elevatum diutinum (EED) is a&#x000a0;histopathological&#x000a0;differential diagnosis&#x000a0;for granuloma faciale include and can show similar&#x000a0;histological features like&#x000a0;fibrosing vasculitis. It is possible that both EED and GF have a common underlying&#x000a0;pathogenic mechanism. The main difference between these two entities is clinical, as EED usually presents as multiple lesions on the extensor surfaces of the joints, and GF usually a single facial lesion. The diagnosis is more challenging when EED presents on the face, or in the case of extra facial localization with GF.<xref ref-type="bibr" rid="article-22401.r5">[5]</xref><xref ref-type="bibr" rid="article-22401.r8">[8]</xref><xref ref-type="bibr" rid="article-22401.r15">[15]</xref>&#x000a0;However, a high number of eosinophils strongly favors the diagnosis of GF. On the other hand, the granulomatous nodules in the histopathologic examination&#x000a0;are present in some cases of EED.<xref ref-type="bibr" rid="article-22401.r15">[15]</xref>&#x000a0;Additionally, EED commonly correlates with some underlying disease, mainly hematological abnormalities, autoimmune conditions, HIV infections, other infectious diseases, and insect bites. However, granuloma faciale include is rarely associated with other&#x000a0;systemic diseases.<xref ref-type="bibr" rid="article-22401.r15">[15]</xref></p>
      </sec>
      <sec id="article-22401.s11" sec-type="Treatment Planning ">
        <title>Treatment Planning </title>
        <p>Topical treatments are considered to be first-line therapy in granuloma faciale include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Calcineurin inhibitors especially tacrolimus&#x000a0;are considered to be the first line topical treatment for GF. Topical calcineurin inhibitors decrease T-cell activation and also decrease the upregulation of interleukin-2<xref ref-type="bibr" rid="article-22401.r5">[5]</xref>; Tacrolimus 0.1% ointment, applied twice daily, seems to be the most&#x000a0;effective primary treatment option.<xref ref-type="bibr" rid="article-22401.r16">[16]</xref><xref ref-type="bibr" rid="article-22401.r17">[17]</xref><xref ref-type="bibr" rid="article-22401.r18">[18]</xref><xref ref-type="bibr" rid="article-22401.r19">[19]</xref><xref ref-type="bibr" rid="article-22401.r20">[20]</xref>&#x000a0;However, lesion clearance might take several months, and healing may require up to&#x000a0;2 to 6 months of treatment in most cases.<xref ref-type="bibr" rid="article-22401.r21">[21]</xref><xref ref-type="bibr" rid="article-22401.r22">[22]</xref><xref ref-type="bibr" rid="article-22401.r23">[23]</xref><xref ref-type="bibr" rid="article-22401.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p>Corticosteroids as topical or intralesional therapy have been reported to be effective in granuloma faciale include with variable results. Intralesional corticosteroids can are an option in combination with cryotherapy. The most common dose of intralesional corticosteroids used is triamcinolone acetonide 5 to 20 mg/ml once weekly or once monthly infiltrations.<xref ref-type="bibr" rid="article-22401.r25">[25]</xref><xref ref-type="bibr" rid="article-22401.r26">[26]</xref><xref ref-type="bibr" rid="article-22401.r27">[27]</xref><xref ref-type="bibr" rid="article-22401.r28">[28]</xref><xref ref-type="bibr" rid="article-22401.r29">[29]</xref><xref ref-type="bibr" rid="article-22401.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p>A case report discussed the efficacy of topical dapsone 5% gel with a good outcome.<xref ref-type="bibr" rid="article-22401.r31">[31]</xref></p>
          </list-item>
          <list-item>
            <p>Intralesional rituximab was tried in three cases at a dose of 10 mg/ml once monthly, with relatively good results.<xref ref-type="bibr" rid="article-22401.r32">[32]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>Systemic treatments:</p>
        <list list-type="bullet">
          <list-item>
            <p>Dapsone at dose 50 to 150 mg/day&#x000a0;has demonstrated effectiveness as a treatment option for granuloma faciale.<xref ref-type="bibr" rid="article-22401.r33">[33]</xref><xref ref-type="bibr" rid="article-22401.r34">[34]</xref><xref ref-type="bibr" rid="article-22401.r35">[35]</xref> Dapsone has an anti-inflammatory, antimicrobial and antiprotozoal effects. The mechanism of action is not well understood, and the anti-inflammatory effect could be related to several mechanisms including inhibition of prostaglandin synthesis and production, and prevention of the extravasation of neutrophils to the lesional site.<xref ref-type="bibr" rid="article-22401.r36">[36]</xref><xref ref-type="bibr" rid="article-22401.r37">[37]</xref></p>
          </list-item>
          <list-item>
            <p>Systemic corticosteroids have been reported to be effective but with only partial improvement in most cases.<xref ref-type="bibr" rid="article-22401.r38">[38]</xref><xref ref-type="bibr" rid="article-22401.r39">[39]</xref></p>
          </list-item>
          <list-item>
            <p>Clofazimine is an anti-leprosy treatment with anti-inflammatory and anti-proliferative effects for lymphocytes and carcinoma cells. It has received minimal discussion as a treatment of GF at a dose of 300 mg/day with good effect after 3 to 5 months of treatment.<xref ref-type="bibr" rid="article-22401.r40">[40]</xref><xref ref-type="bibr" rid="article-22401.r41">[41]</xref><xref ref-type="bibr" rid="article-22401.r33">[33]</xref></p>
          </list-item>
        </list>
        <p>Surgical and other therapies:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cryotherapy with liquid nitrogen as a single treatment seems to be a good choice for treating GF.<xref ref-type="bibr" rid="article-22401.r42">[42]</xref></p>
          </list-item>
          <list-item>
            <p>Various types of laser&#x000a0;are discussed in medical literature with the variable outcomes depending on the lesion, type of laser used, and the operating physician as well, and this includes:&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="order">
          <list-item>
            <p>Pulsed dye laser (PDL). It targets oxyhemoglobin in blood vessels. Good cosmetic outcomes have been reported, especially for superficial lesions. For the maximal possible benefit, several sittings may be necessary. The time interval between laser treatments is about 2 to 4 months. PDL correlates with a lower risk of scarring&#x000a0;as compared to other types of laser, and its main side effects are pain during the procedure and bruising after the procedure.<xref ref-type="bibr" rid="article-22401.r43">[43]</xref><xref ref-type="bibr" rid="article-22401.r44">[44]</xref><xref ref-type="bibr" rid="article-22401.r45">[45]</xref><xref ref-type="bibr" rid="article-22401.r46">[46]</xref></p>
          </list-item>
          <list-item>
            <p>Potassium-titanyl-phosphate (KTP) - 532-nm has been reported to be effective with good results reported after 5 to 10 days of daily treatment, without significant scarring.<xref ref-type="bibr" rid="article-22401.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Carbon-dioxide (CO2) laser.<xref ref-type="bibr" rid="article-22401.r47">[47]</xref><xref ref-type="bibr" rid="article-22401.r48">[48]</xref><xref ref-type="bibr" rid="article-22401.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p>Argon laser at 480 to 520 nm. This type of laser has a more selective effect on oxyhemoglobin than CO2 laser, but it causes further non-specific tissue destruction due to diffusion of the created heat over a large area.<xref ref-type="bibr" rid="article-22401.r49">[49]</xref><xref ref-type="bibr" rid="article-22401.r45">[45]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Phototherapy including topical psoralen-ultraviolet A (PUVA).<xref ref-type="bibr" rid="article-22401.r50">[50]</xref></p>
          </list-item>
          <list-item>
            <p>Surgical excision with and without grafting. Dermabrasion is a therapeutic choice as well.<xref ref-type="bibr" rid="article-22401.r51">[51]</xref><xref ref-type="bibr" rid="article-22401.r12">[12]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22401.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Primary care providers and nurse practitioners who see facial lesions should refer these patients to the dermatologist for definitive workup. It is essential to evaluate granuloma faciale along with the dermatopathologist to ensure the accuracy of diagnosis because of the large number of clinical and histological differentials. an interprofessional team approach that includes physicians, nurse practitioners, PAs, and pharmacists gives the best opportunity for successful case management and patient care.</p>
        <p>Surgical treatment, especially for facial lesions, needs to be planned in collaboration with a plastic surgeon.</p>
      </sec>
      <sec id="article-22401.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22401&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22401">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/granuloma-faciale/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22401">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22401/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22401">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-22401.s14">
        <title>References</title>
        <ref id="article-22401.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wigley</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic Granuloma.&#x000a0;? Sarcoid of Boeck.</article-title>
            <source>Proc R Soc Med</source>
            <year>1945</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>125</fpage>
            <page-range>125-6</page-range>
            <pub-id pub-id-type="pmid">19992999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliveira</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Ianhez</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Marques</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Marques</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale: clinical, morphological and immunohistochemical aspects in a series of 10 patients.</article-title>
            <source>An Bras Dermatol</source>
            <year>2016</year>
            <season>Nov-Dec</season>
            <volume>91</volume>
            <issue>6</issue>
            <fpage>803</fpage>
            <page-range>803-807</page-range>
            <pub-id pub-id-type="pmid">28099604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ortonne</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wechsler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bagot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grosshans</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cribier</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale: a clinicopathologic study of 66 patients.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>53</volume>
            <issue>6</issue>
            <fpage>1002</fpage>
            <page-range>1002-9</page-range>
            <pub-id pub-id-type="pmid">16310061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moloney</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Muir</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Extrafacial Granuloma Faciale: A Case Report and Brief Review.</article-title>
            <source>Case Rep Dermatol</source>
            <year>2017</year>
            <season>May-Aug</season>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>79</fpage>
            <page-range>79-85</page-range>
            <pub-id pub-id-type="pmid">28868005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lindhaus</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Elsner</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Granuloma Faciale Treatment: A Systematic Review.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2018</year>
            <month>Jan</month>
            <day>12</day>
            <volume>98</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-18</page-range>
            <pub-id pub-id-type="pmid">28880343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nigar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dhillon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Matin</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic angiocentric fibrosis and extrafacial granuloma faciale.</article-title>
            <source>Histopathology</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>729</fpage>
            <page-range>729-31</page-range>
            <pub-id pub-id-type="pmid">17927606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sina</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale: the role of dapsone and prior irradiation on the cause of the disease.</article-title>
            <source>Cutis</source>
            <year>1984</year>
            <month>May</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>478</fpage>
            <page-range>478-9, 482</page-range>
            <pub-id pub-id-type="pmid">6478871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marcoval</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Peyr</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale: a clinicopathological study of 11 cases.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>269</fpage>
            <page-range>269-73</page-range>
            <pub-id pub-id-type="pmid">15280847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Radin</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Mehregan</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale: distribution of the lesions and review of the literature.</article-title>
            <source>Cutis</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>72</volume>
            <issue>3</issue>
            <fpage>213</fpage>
            <page-range>213-9; quiz 208</page-range>
            <pub-id pub-id-type="pmid">14533833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnadas</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Curell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Alomar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Direct immunofluorescence in granuloma faciale: a case report and review of literature.</article-title>
            <source>J Cutan Pathol</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>7</issue>
            <fpage>508</fpage>
            <page-range>508-11</page-range>
            <pub-id pub-id-type="pmid">16872475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lallas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sidiropoulos</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lefaki</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tzellos</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sotiriou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Apalla</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Photoletter to the editor: Dermoscopy of granuloma faciale.</article-title>
            <source>J Dermatol Case Rep</source>
            <year>2012</year>
            <month>Jun</month>
            <day>30</day>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>59</fpage>
            <page-range>59-60</page-range>
            <pub-id pub-id-type="pmid">22826723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ludwig</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Allam</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Bieber</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Novak</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>New treatment modalities for granuloma faciale.</article-title>
            <source>Br J Dermatol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>149</volume>
            <issue>3</issue>
            <fpage>634</fpage>
            <page-range>634-7</page-range>
            <pub-id pub-id-type="pmid">14511001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tomson</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sterling</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Salvary</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale treated successfully with topical tacrolimus.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>424</fpage>
            <page-range>424-5</page-range>
            <pub-id pub-id-type="pmid">19175788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frankel</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Soltani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Medenica</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Rippon</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Tinea of the face caused by Trichophyton rubrum with histologic changes of granuloma faciale.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1988</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>2 Pt 2</issue>
            <fpage>403</fpage>
            <page-range>403-6</page-range>
            <pub-id pub-id-type="pmid">3343409</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ziemer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koehler</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Weyers</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Erythema elevatum diutinum - a chronic leukocytoclastic vasculitis microscopically indistinguishable from granuloma faciale?</article-title>
            <source>J Cutan Pathol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>38</volume>
            <issue>11</issue>
            <fpage>876</fpage>
            <page-range>876-83</page-range>
            <pub-id pub-id-type="pmid">21883365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lima</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Maquin&#x000e9;</surname>
                <given-names>G&#x000c1;</given-names>
              </name>
              <name>
                <surname>Silva Junior</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Schettini</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale: a good therapeutic response with the use of topical tacrolimus.</article-title>
            <source>An Bras Dermatol</source>
            <year>2015</year>
            <season>Sep-Oct</season>
            <volume>90</volume>
            <issue>5</issue>
            <fpage>735</fpage>
            <page-range>735-7</page-range>
            <pub-id pub-id-type="pmid">26560220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cecchi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pavesi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bartoli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Brunetti</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Topical tacrolimus in the treatment of granuloma faciale.</article-title>
            <source>Int J Dermatol</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>49</volume>
            <issue>12</issue>
            <fpage>1463</fpage>
            <page-range>1463-5</page-range>
            <pub-id pub-id-type="pmid">21091691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;rez-Robayna</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Garc&#x000ed;a</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Hern&#x000e1;ndez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Guimer&#x000e1;</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>S&#x000e1;ez</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Successful response to topical tacrolimus for a granuloma faciale in an elderly patient.</article-title>
            <source>Dermatology</source>
            <year>2009</year>
            <volume>219</volume>
            <issue>4</issue>
            <fpage>359</fpage>
            <page-range>359-60</page-range>
            <pub-id pub-id-type="pmid">19797891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitchell</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of granuloma faciale with tacrolimus.</article-title>
            <source>Dermatol Online J</source>
            <year>2004</year>
            <month>Oct</month>
            <day>15</day>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>23</fpage>
            <pub-id pub-id-type="pmid">15530313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eetam</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ertekin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Unal</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Alper</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale: Is it a new indication for pimecrolimus? A case report.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2006</year>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>238</fpage>
            <page-range>238-40</page-range>
            <pub-id pub-id-type="pmid">16971320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marcoval</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bordas</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Peyr&#x000ed;</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale: treatment with topical tacrolimus.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>55</volume>
            <issue>5 Suppl</issue>
            <fpage>S110</fpage>
            <page-range>S110-1</page-range>
            <pub-id pub-id-type="pmid">17052523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jedlickov&#x000e1;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Feit</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Semr&#x000e1;dov&#x000e1;</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale successfully treated with topical tacrolimus: a case report.</article-title>
            <source>Acta Dermatovenerol Alp Pannonica Adriat</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-6</page-range>
            <pub-id pub-id-type="pmid">18454269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patterson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Coutts</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale successfully treated with topical tacrolimus.</article-title>
            <source>Australas J Dermatol</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>50</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-9</page-range>
            <pub-id pub-id-type="pmid">19659988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dourmishev</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ouzounova-Raykova</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Broshtilova</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Miteva</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale effectively treated with topical pimecrolimus.</article-title>
            <source>Acta Dermatovenerol Croat</source>
            <year>2014</year>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>305</fpage>
            <page-range>305-7</page-range>
            <pub-id pub-id-type="pmid">25580794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dowlati</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Firooz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dowlati</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale: successful treatment of nine cases with a combination of cryotherapy and intralesional corticosteroid injection.</article-title>
            <source>Int J Dermatol</source>
            <year>1997</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>548</fpage>
            <page-range>548-51</page-range>
            <pub-id pub-id-type="pmid">9268759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zargari</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Disseminated granuloma faciale.</article-title>
            <source>Int J Dermatol</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>210</fpage>
            <page-range>210-2</page-range>
            <pub-id pub-id-type="pmid">15009395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Vaishampayan</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Vaidya</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Keloidal granuloma faciale with extrafacial lesions.</article-title>
            <source>Indian J Dermatol Venereol Leprol</source>
            <year>2005</year>
            <season>Sep-Oct</season>
            <volume>71</volume>
            <issue>5</issue>
            <fpage>345</fpage>
            <page-range>345-7</page-range>
            <pub-id pub-id-type="pmid">16394461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mashood</surname>
                <given-names>AA</given-names>
              </name>
              <collab>Simeen-ber-Rahman</collab>
            </person-group>
            <article-title>Granuloma faciale -- an unusual presentation.</article-title>
            <source>J Coll Physicians Surg Pak</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>296</fpage>
            <page-range>296-7</page-range>
            <pub-id pub-id-type="pmid">16624198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kanwar</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Radotra</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Extrafacial granuloma faciale: report of a case.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>21</volume>
            <issue>9</issue>
            <fpage>1284</fpage>
            <page-range>1284-6</page-range>
            <pub-id pub-id-type="pmid">17894740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakkour</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Madan</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Rhinophyma-like granuloma faciale successfully treated with carbon dioxide laser.</article-title>
            <source>Br J Dermatol</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>170</volume>
            <issue>2</issue>
            <fpage>474</fpage>
            <page-range>474-5</page-range>
            <pub-id pub-id-type="pmid">24111815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Babalola</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kristjansson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Whitaker-Worth</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McCusker</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale treated with topical dapsone: a case report.</article-title>
            <source>Dermatol Online J</source>
            <year>2014</year>
            <month>Aug</month>
            <day>17</day>
            <volume>20</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">25148282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morgado-Carrasco</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Giavedoni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mascar&#x000f3;</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Iranzo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Assessment of Treatment of Refractory Granuloma Faciale With Intralesional Rituximab.</article-title>
            <source>JAMA Dermatol</source>
            <year>2018</year>
            <month>Nov</month>
            <day>01</day>
            <volume>154</volume>
            <issue>11</issue>
            <fpage>1312</fpage>
            <page-range>1312-1315</page-range>
            <pub-id pub-id-type="pmid">30193300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holme</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Laidler</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Holt</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Concurrent granuloma faciale and eosinophilic angiocentric fibrosis.</article-title>
            <source>Br J Dermatol</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>153</volume>
            <issue>4</issue>
            <fpage>851</fpage>
            <page-range>851-3</page-range>
            <pub-id pub-id-type="pmid">16181479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Naik</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>HK</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale with extrafacial involvement and response to tacrolimus.</article-title>
            <source>J Cutan Aesthet Surg</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>150</fpage>
            <page-range>150-2</page-range>
            <pub-id pub-id-type="pmid">23060713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fumo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Patta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Milo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pilloni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Atzori</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A nose for trouble. Diagnosis: Granuloma faciale.</article-title>
            <source>Indian J Dermatol Venereol Leprol</source>
            <year>2015</year>
            <season>Jan-Feb</season>
            <volume>81</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-4</page-range>
            <pub-id pub-id-type="pmid">25566920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zampeli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Moutsopoulos</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Dapsone: an old drug effective for subacute cutaneous lupus erythematosus.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2019</year>
            <month>May</month>
            <day>01</day>
            <volume>58</volume>
            <issue>5</issue>
            <fpage>920</fpage>
            <page-range>920-921</page-range>
            <pub-id pub-id-type="pmid">30615176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pfeiffer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wozel</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Dapsone and sulfones in dermatology: overview and update.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>308</fpage>
            <page-range>308-9</page-range>
            <pub-id pub-id-type="pmid">12582416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yuan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>A case of granuloma faciale successfully treated with oral prednisone, tranilast and thalidomide.</article-title>
            <source>Postepy Dermatol Alergol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>109</fpage>
            <page-range>109-112</page-range>
            <pub-id pub-id-type="pmid">29599681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sand</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Thomsen</surname>
                <given-names>SF</given-names>
              </name>
            </person-group>
            <article-title>Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients.</article-title>
            <source>Dermatol Ther</source>
            <year>2015</year>
            <season>May-Jun</season>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>158</fpage>
            <page-range>158-65</page-range>
            <pub-id pub-id-type="pmid">25731720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wollina</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Karte</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Geyer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stuhlert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bocker</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Clofazimine in inflammatory facial dermatosis--granuloma faciale and lipogranulomatosis subcutanea (Rothmann-Makai).</article-title>
            <source>Acta Derm Venereol</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>76</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-9</page-range>
            <pub-id pub-id-type="pmid">8721503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000f3;mez-de la Fuente</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>del Rio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rodriguez-Peralto</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Iglesias</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale mimicking rhinophyma: response to clofazimine.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2000</year>
            <season>Mar-Apr</season>
            <volume>80</volume>
            <issue>2</issue>
            <fpage>144</fpage>
            <pub-id pub-id-type="pmid">10877139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Panagiotopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Anyfantakis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rallis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chasapi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Stavropoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Boubouka</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Katsambas</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Assessment of the efficacy of cryosurgery in the treatment of granuloma faciale.</article-title>
            <source>Br J Dermatol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>154</volume>
            <issue>2</issue>
            <fpage>357</fpage>
            <page-range>357-60</page-range>
            <pub-id pub-id-type="pmid">16433810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fikrle</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pizinger</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Granuloma Faciale treated with 595-nm pulsed dye laser.</article-title>
            <source>Dermatol Surg</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>102</fpage>
            <page-range>102-4</page-range>
            <pub-id pub-id-type="pmid">21070474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hruza</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Ammirati</surname>
                <given-names>CT</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale treated with 595-nm pulsed dye laser.</article-title>
            <source>Dermatol Surg</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>37</volume>
            <issue>7</issue>
            <fpage>1060</fpage>
            <page-range>1060-1</page-range>
            <pub-id pub-id-type="pmid">21711410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheung</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Lanigan</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale treated with the pulsed-dye laser: a case series.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>373</fpage>
            <page-range>373-5</page-range>
            <pub-id pub-id-type="pmid">15953073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erceg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Jong</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>van de Kerkhof</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Seyger</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>The efficacy of pulsed dye laser treatment for inflammatory skin diseases: a systematic review.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>609</fpage>
            <page-range>609-615.e8</page-range>
            <pub-id pub-id-type="pmid">23711766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Keloidal granuloma faciale after CO2 laser treatment for melanocytic naevus.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2009</year>
            <month>May</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>611</fpage>
            <page-range>611-2</page-range>
            <pub-id pub-id-type="pmid">19415815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wheeland</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Ashley</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Wheeland</surname>
                <given-names>DN</given-names>
              </name>
            </person-group>
            <article-title>Carbon dioxide laser treatment of granuloma faciale.</article-title>
            <source>J Dermatol Surg Oncol</source>
            <year>1984</year>
            <month>Sep</month>
            <volume>10</volume>
            <issue>9</issue>
            <fpage>730</fpage>
            <page-range>730-3</page-range>
            <pub-id pub-id-type="pmid">6434613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Apfelberg</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Druker</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Maser</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Lash</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Spence</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Deneau</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale. Treatment with the argon laser.</article-title>
            <source>Arch Dermatol</source>
            <year>1983</year>
            <month>Jul</month>
            <volume>119</volume>
            <issue>7</issue>
            <fpage>573</fpage>
            <page-range>573-6</page-range>
            <pub-id pub-id-type="pmid">6859900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hudson</surname>
                <given-names>LD</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale: treatment with topical psoralen and UVA.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1983</year>
            <month>Apr</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>559</fpage>
            <pub-id pub-id-type="pmid">6853786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22401.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bergfeld</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Scholes</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Roenigk</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Granuloma faciale--treatment by dermabrasion. Report of a case.</article-title>
            <source>Cleve Clin Q</source>
            <year>1970</year>
            <month>Oct</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>215</fpage>
            <page-range>215-8</page-range>
            <pub-id pub-id-type="pmid">5520807</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
